CLINICAL RESEARCH: CARDIAC IMAGING
Cardiac Iodine-123 Metaiodobenzylguanidine Imaging Predicts Sudden Cardiac Death Independently of Left Ventricular Ejection Fraction in Patients With Chronic Heart Failure and Left Ventricular Systolic DysfunctionResults From a Comparative Study With Signal-Averaged Electrocardiogram, Heart Rate Variability, and QT Dispersion
Shunsuke Tamaki, MD*,*,
Takahisa Yamada, MD*,
Yuji Okuyama, MD*,
Takashi Morita, MD*,
Shoji Sanada, MD*,
Yasumasa Tsukamoto, MD*,
Masaharu Masuda, MD*,
Keiji Okuda, MD*,
Yusuke Iwasaki, MD*,
Taku Yasui, MD*,
Masatsugu Hori, MD and
Masatake Fukunami, MD*
* Division of Cardiology, Osaka General Medical Center, Osaka, Japan
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
Manuscript received April 7, 2008;
revised manuscript received October 20, 2008,
accepted October 26, 2008.
* Reprint requests and correspondence: Dr. Shunsuke Tamaki, Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka 558-8558, Japan (Email: tamaki-shunsuke{at}mwc.biglobe.ne.jp).
Objectives: We prospectively compared the predictive value of cardiac iodine-123 metaiodobenzylguanidine (MIBG) imaging for sudden cardiac death (SCD) with that of the signal-averaged electrocardiogram (SAECG), heart rate variability (HRV), and QT dispersion in patients with chronic heart failure (CHF).
Background: Cardiac MIBG imaging predicts prognosis of CHF patients. However, the long-term predictive value of MIBG imaging for SCD in this population remains to be elucidated.
Methods: At entry, cardiac MIBG imaging, SAECG, 24-h Holter monitoring, and standard 12-lead electrocardiography (ECG) were performed in 106 consecutive stable CHF outpatients with a radionuclide left ventricular ejection fraction (LVEF) <40%. The cardiac MIBG washout rate (WR) was obtained from MIBG imaging. Furthermore, the time and frequency domain HRV parameters were calculated from 24-h Holter recordings, and QT dispersion was measured from the 12-lead ECG.
Results: During a follow-up period of 65 ± 31 months, 18 of 106 patients died suddenly. A multivariate Cox analysis revealed that WR and LVEF were significantly and independently associated with SCD, whereas the SAECG, HRV parameters, or QT dispersion were not. Patients with an abnormal WR (>27%) had a significantly higher risk of SCD (adjusted hazard ratio: 4.79, 95% confidence interval: 1.55 to 14.76). Even when confined to the patients with LVEF >35%, SCD was significantly more frequently observed in the patients with than without an abnormal WR (p = 0.02).
Conclusions: Cardiac MIBG WR, but not SAECG, HRV, or QT dispersion, is a powerful predictor of SCD in patients with mild-to-moderate CHF, independently of LVEF.
Key Words: cardiac I-123 metaiodobenzylguanidine imaging chronic heart failure sudden cardiac death
|
Abbreviations and Acronyms
| | AUC = area under the curve | | CHF = chronic heart failure | | ECG = electrocardiography/electrocardiogram | | fQRSd = the duration of filtered QRS complex | | H/M = heart-to-mediastinum ratio | | HRV = heart rate variability | | LAS40 = the duration of low-amplitude signals <40 µV in the terminal portion of filtered QRS complex | | LVEF = left ventricular ejection fraction | | MIBG = metaiodobenzylguanidine | | NN = normal-to-normal | | NYHA = New York Heart Association | | QTc = corrected QT interval | | RMS40 = the root mean square voltage for the last 40 ms of filtered QRS complex | | ROI = region-of-interest | | SAECG = signal-averaged electrocardiogram | | SCD = sudden cardiac death | | WR = washout rate |
|
Related Article
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, and J. Butler
The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
J. Am. Coll. Cardiol.,
November 3, 2009;
54(19):
1747 - 1762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Caldwell and J. M. Link
Imaging Left Ventricular Muscarinic Receptor Heterogeneity: A Tool to Evaluate Individuals at Risk for Sudden Death?
Circ Cardiovasc Imaging,
September 1, 2009;
2(5):
353 - 355.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Heston and R. L. Wahl
Clinical significance of iodine-123 metaiodobenzylguanidine cardiac imaging.
J. Am. Coll. Cardiol.,
August 4, 2009;
54(6):
575 - 576.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tamaki, T. Yamada, and M. Fukunami
Reply
J. Am. Coll. Cardiol.,
August 4, 2009;
54(6):
576 - 576.
[Full Text]
[PDF]
|
 |
|
|